United States · FDA National Drug Code directory
Skytrofa
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 73362-012_4b962793-361f-4194-8292-af51f5ceaabb
- Product NDC
- 73362-012
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- Lonapegsomatropin-tcgd
- Labeler
- Ascendis Pharma Endocrinology, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20250725
- Source listing expiry
- 20271231
Source-listed ingredients
- LONAPEGSOMATROPIN — .7 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 4 BLISTER PACK in 1 CARTON (73362-012-01) / 1 CARTRIDGE in 1 BLISTER PACK (73362-012-02) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTRIDGE · 73362-012-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →